Tag Archives: ReNeuron

Exosomes start to deliver deals


Some biotech investors had probably never heard of exosomes until Codiak’s chief executive, Doug Williams, made his pitch at the JP Morgan conference two weeks ago. But the area has been gaining traction, and Jazz’s $56m up-front...

Read More »

ReNeuron Publishes Exosome Nanomedicine Platform Data

exosome rna

LONDON (Alliance News) – Stem-cell therapy development company ReNeuron Group PLC Tuesday said data related to its exosome nanomedicine platform has been published in peer-reviewed scientific journal PLOS ONE. The UK-based company is researching the “therapeutic potential of exosomes derived ...

Read More »